Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.055 USD | -5.80% | +16.69% | -23.91% |
May. 09 | Transcript : Bluebird bio, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 06 | Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy | CI |
Financials (USD)
Sales 2023 * | 37.03M | Sales 2024 * | 125M | Capitalization | 216M |
---|---|---|---|---|---|
Net income 2023 * | -199M | Net income 2024 * | -228M | EV / Sales 2023 * | 0.36 x |
Net cash position 2023 * | 203M | Net cash position 2024 * | 146M | EV / Sales 2024 * | 0.56 x |
P/E ratio 2023 * |
-0.67
x | P/E ratio 2024 * |
-0.7
x | Employees | 323 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 99.62% |
Latest transcript on bluebird bio, Inc.
1 day | -5.80% | ||
1 week | +17.25% | ||
Current month | +18.93% | ||
1 month | -11.34% | ||
3 months | -3.21% | ||
6 months | -64.60% | ||
Current year | -23.55% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Obenshain
CEO | Chief Executive Officer | 51 | 15-12-31 |
Director of Finance/CFO | 51 | 22-11-06 | |
Melissa Bonner
CTO | Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Vachon
CHM | Chairman | 65 | 14-07-15 |
Nick Leschly
BRD | Director/Board Member | 51 | 10-02-28 |
Richard Paulson
BRD | Director/Board Member | 56 | 23-04-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 0 M€ | -4.02% | ||
0.11% | 0 M€ | +4.20% | - | |
0.10% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 1.05 | -6.25% | 2 247 177 |
24-05-09 | 1.12 | +14.92% | 11,517,964 |
24-05-08 | 0.9746 | -3.50% | 7,679,327 |
24-05-07 | 1.01 | +1.00% | 3,550,756 |
24-05-06 | 1 | +11.14% | 20,043,956 |
Delayed Quote Nasdaq, May 10, 2024 at 10:02 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.55% | 216M | |
+3.15% | 108B | |
+10.39% | 104B | |
+1.05% | 22.33B | |
-11.89% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.18% | 17.64B | |
+6.66% | 14.05B | |
+36.28% | 12.51B |
- Stock Market
- Equities
- BLUE Stock